These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28444739)

  • 1. Incidence and survival trends in mantle cell lymphoma.
    Epperla N; Hamadani M; Fenske TS; Costa LJ
    Br J Haematol; 2018 Jun; 181(5):703-706. PubMed ID: 28444739
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized medicine in lymphoma: is it worthwhile? The mantle cell lymphoma experience.
    Dreyling M; Ferrero S;
    Haematologica; 2015 Jun; 100(6):706-8. PubMed ID: 26034112
    [No Abstract]   [Full Text] [Related]  

  • 3. Early-stage mantle cell lymphoma-a rare entity with special characteristics and needs for treatment.
    Specht L;
    Ann Hematol; 2020 Dec; 99(12):2963-2964. PubMed ID: 32914247
    [No Abstract]   [Full Text] [Related]  

  • 4. Mantle Cell Lymphoma: Is It Time for a New Treatment Paradigm?
    Goy A
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1345-1370. PubMed ID: 27888885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receiving treatment at a specialist centre confers an overall survival benefit for patients with mantle cell lymphoma.
    McCulloch R; Smith A; Crosbie N; Patmore R; Rule S
    Br J Haematol; 2019 Jun; 185(5):1002-1004. PubMed ID: 30474177
    [No Abstract]   [Full Text] [Related]  

  • 6. Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?
    Sweetenham JW
    Bone Marrow Transplant; 2001 Nov; 28(9):813-20. PubMed ID: 11781640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.
    Dietrich S; Tielesch B; Rieger M; Nickelsen M; Pott C; Witzens-Harig M; Kneba M; Schmitz N; Ho AD; Dreger P
    Cancer; 2011 May; 117(9):1901-10. PubMed ID: 21509767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indolent mantle cell lymphoma.
    Hsi ED; Martin P
    Leuk Lymphoma; 2014 Apr; 55(4):761-7. PubMed ID: 23927395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mantle Cell Lymphoma-Time to Dismantle the Treatment Paradox.
    Yavorkovsky LL
    JAMA Oncol; 2018 May; 4(5):626-627. PubMed ID: 29494738
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma.
    Lee HJ; Badillo M; Romaguera J; Wang M
    Br J Haematol; 2019 Feb; 184(3):460-462. PubMed ID: 29527676
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma.
    Barzenje DA; Holte H; Fosså A; Ghanima W; Liestøl K; Delabie J; Kolstad A
    Leuk Lymphoma; 2017 Mar; 58(3):623-632. PubMed ID: 27389974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma.
    Berger MD; Branger G; Leibundgut K; Baerlocher GM; Seipel K; Mueller BU; Gregor M; Ruefer A; Pabst T
    Leuk Res; 2015 Jun; 39(6):561-7. PubMed ID: 25890431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the primary site as a prognostic tool for nodal mantle cell lymphoma: a SEER-based study.
    Kamel MG; El-Qushayri AE; Sayed AK; Huy NT
    J Comp Eff Res; 2020 Aug; 9(12):861-876. PubMed ID: 32885984
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ten years progression-free survival obtained in a patient with mantle cell lymphoma].
    Wysokińska E; Kolak A; Starosławska E; Kieszko D; Kamińska M; Surdyka D; Mocarska A; Burdan F
    Pol Merkur Lekarski; 2015 May; 38(227):280-2. PubMed ID: 26039024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience.
    Bhatt VR; Loberiza FR; Smith LM; Armitage JO; Greiner TC; Bast M; Lunning MA; Bierman PJ; Vose JM; Bociek RG
    Leuk Lymphoma; 2016; 57(6):1327-34. PubMed ID: 26377137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort study.
    Glimelius I; Smedby KE; Eloranta S; Jerkeman M; Weibull CE
    Br J Haematol; 2020 Apr; 189(1):106-116. PubMed ID: 31721156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma.
    Thieblemont C; Antal D; Lacotte-Thierry L; Delwail V; Espinouse D; Michallet AS; Traulle C; Bouafia-Sauvy F; Giraud C; Salles G; Guilhot F; Coiffier B
    Cancer; 2005 Oct; 104(7):1434-41. PubMed ID: 16104036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syngeneic transplant in mantle cell lymphoma: a rare event and review of the literature.
    Engman CA; Hill JM; Meehan KR
    Clin Adv Hematol Oncol; 2009 May; 7(5):321-3. PubMed ID: 19521320
    [No Abstract]   [Full Text] [Related]  

  • 19. TCL1 expression predicts overall survival in patients with mantle cell lymphoma.
    Shin SJ; Roh J; Cha HJ; Choi YD; Kim JM; Min SK; Kim JE; Eom DW; Lee H; Kim HJ; Yoon DH; Suh C; Huh J
    Eur J Haematol; 2015 Dec; 95(6):583-94. PubMed ID: 25688912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma.
    Murali S; Winton E; Waller EK; Heffner LT; Lonial S; Flowers C; Kaufman J; Arellano M; Lechowicz MJ; Mann KP; Khoury HJ; Langston AA
    Bone Marrow Transplant; 2008 Oct; 42(8):529-34. PubMed ID: 18622414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.